Chemical activators of V1rd8 can be understood through various biochemical pathways that lead to its functional activation. Calcium ionophore A23187 and Ionomycin serve as facilitators to increase the intracellular calcium concentration, which is a well-known secondary messenger in numerous cellular processes. The elevated calcium levels can directly activate V1rd8 by altering its conformation or by engaging with calcium-binding domains within the protein structure, leading to a change in its activity state. Similarly, Thapsigargin causes an increase in intracellular calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), resulting in calcium release from the endoplasmic reticulum and subsequent activation of V1rd8. Bay K8644 further contributes to the rise in intracellular calcium levels by acting as a calcium channel agonist, promoting the influx of calcium ions into the cell and activating V1rd8 in the process.
In parallel, Forskolin and Isoproterenol both act to elevate cAMP levels within the cell. Forskolin directly stimulates adenylate cyclase, leading to an increase in cAMP production, while Isoproterenol activates beta-adrenergic receptors that signal through G-protein coupled receptor pathways to also increase cAMP. The rise in cAMP activates protein kinase A (PKA), which can then phosphorylate V1rd8, leading to its activation. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which has numerous substrates within the cell, one of which may include V1rd8, resulting in its phosphorylation and activation. The cAMP analogs, 8-Bromo-cAMP and Dibutyryl-cAMP, bypass cell surface receptors and directly activate cAMP-dependent pathways, which can then lead to the activation of V1rd8. Additionally, Hydrogen peroxide serves as an oxidative stressor that can activate signaling pathways involving V1rd8, while the nitric oxide donor SNAP can activate guanylate cyclase, increasing cGMP levels, which in turn can lead to the activation of V1rd8. Lastly, although not a direct activator, the Bradykinin B2 receptor agonist can engage its receptor, potentially leading to an increase in intracellular Ca2+ levels and the subsequent activation of V1rd8. Through these diverse yet interconnected pathways, the activators collectively orchestrate the stimulation and functional activation of V1rd8.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Activates V1rd8 by increasing intracellular calcium concentration, which is a secondary messenger known to activate V1rd8. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Elevates cAMP levels which can enhance the PKA pathway, leading to phosphorylation and activation of V1rd8. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate and thereby activate V1rd8. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Like A23187, ionomycin raises intracellular calcium levels, potentially leading to the activation of V1rd8. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Activates beta-adrenergic receptors causing a cascade that increases cAMP, which can lead to V1rd8 activation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
A cAMP analog that activates cAMP-dependent pathways, potentially leading to the activation of V1rd8. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $30.00 $60.00 $93.00 | 27 | |
Induces oxidative stress, which can activate signaling pathways involving V1rd8. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased intracellular Ca2+ and activation of V1rd8. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
Acts as a calcium channel agonist, which can lead to increased intracellular Ca2+ levels and activation of V1rd8. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
A cAMP analog that penetrates cell membranes and activates cAMP-dependent pathways, which can lead to V1rd8 activation. | ||||||